Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis

We sought to evaluate the efficacy of the purine analogue cladribine in 79 patients with advanced systemic mastocytosis (AdvSM) using data from the ‘German Registry on Disorders of Eosinophils and Mast Cells (GREM)’. The overall response rate according to modified Valent criteria (46 evaluable patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Lübke, Johannes, Naumann, Nicole, Metzgeroth, Georgia, Kreil, Sebastian, Brand, Timo, Horny, Hans-Peter, Sotlar, Karl, Cross, Nicholas C. P., Fabarius, Alice, Valent, Peter, Hofmann, Wolf-Karsten, Reiter, Andreas, Schwaab, Juliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344834/
https://www.ncbi.nlm.nih.gov/pubmed/37012462
http://dx.doi.org/10.1007/s00277-023-05180-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344834/
https://www.ncbi.nlm.nih.gov/pubmed/37012462
http://dx.doi.org/10.1007/s00277-023-05180-y

Ejemplares similares